UFP Technologies [UFPT] vs Abbott Laboratories [ABT] Detailed Stock Comparison

UFP Technologies Inc.

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: UFP Technologies Inc. wins in 9 metrics, Abbott Laboratories wins in 10 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric UFP Technologies Inc. Abbott Laboratories Better
P/E Ratio (TTM) 22.64 25.97 UFP Technologies Inc.
Price-to-Book Ratio 3.60 3.09 Abbott Laboratories
Debt-to-Equity Ratio 36.45 26.79 Abbott Laboratories
PEG Ratio 3.21 -1.41 UFP Technologies Inc.
EV/EBITDA 14.82 13.74 Abbott Laboratories
Profit Margin (TTM) 11.33% 13.90% Abbott Laboratories
Operating Margin (TTM) 14.10% 16.50% Abbott Laboratories
EBITDA Margin (TTM) 14.10% 16.50% Abbott Laboratories
Return on Equity 17.82% 12.36% UFP Technologies Inc.
Return on Assets (TTM) 9.05% 7.52% UFP Technologies Inc.
Free Cash Flow (TTM) $78.98M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return -6.02% -35.92% UFP Technologies Inc.
Price-to-Sales Ratio (TTM) 2.53 3.57 UFP Technologies Inc.
Enterprise Value $1.66B $166.96B Abbott Laboratories
EV/Revenue Ratio 2.76 3.70 UFP Technologies Inc.
Gross Profit Margin (TTM) 28.18% N/A N/A
Revenue per Share (TTM) $78 $26 UFP Technologies Inc.
Earnings per Share (Diluted) $8.75 $3.57 UFP Technologies Inc.
Beta (Stock Volatility) 1.17 0.78 Abbott Laboratories
Short % of Float 18.60% 1.53% Abbott Laboratories

UFP Technologies Inc. vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

UFPT
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
UFP Technologies Inc.0.68%-5.54%12.38%5.91%-1.23%-3.14%
Abbott Laboratories0.02%0.35%-0.65%-23.79%-31.15%-29.97%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
UFP Technologies Inc.-6.02%37.68%280.86%943.62%1,239.62%3,649.57%
Abbott Laboratories-35.92%-17.85%-21.68%118.48%249.25%313.73%

Performance & Financial Health Analysis: UFP Technologies Inc. vs Abbott Laboratories

MetricUFPTABT
Market Information
Market Cap i$1.54B$160.70B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i181,20513,495,583
90 Day Avg. Volume i189,72512,934,461
Last Close$217.86$86.99
52 Week Range$173.86 - $274.93$81.97 - $139.06
% from 52W High-20.76%-37.44%
All-Time High$366.41 (Sep 23, 2024)$142.60 (Dec 27, 2021)
% from All-Time High-40.54%-39.00%
Growth Metrics
Quarterly Revenue Growth0.03%0.08%
Quarterly Earnings Growth0.07%-0.19%
Financial Health
Profit Margin (TTM) i0.11%0.14%
Operating Margin (TTM) i0.14%0.17%
Return on Equity (TTM) i0.18%0.12%
Debt to Equity (MRQ) i36.4526.79
Cash & Liquidity
Book Value per Share (MRQ)$54.95$30.02
Cash per Share (MRQ)$2.63$5.14
Operating Cash Flow (TTM) i$91.91M$10.80B
Levered Free Cash Flow (TTM) i$65.67M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: UFP Technologies Inc. vs Abbott Laboratories

MetricUFPT (Apr 26, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i22.6425.97
Forward P/E i17.3015.29
PEG Ratio i3.21-1.41
Price to Sales (TTM) i2.533.57
Price to Book (MRQ) i3.603.09
Market Capitalization
Market Capitalization i$1.54B$160.70B
Enterprise Value i$1.66B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i2.763.70
Enterprise to EBITDA i14.8213.74
Risk & Other Metrics
Beta i1.170.78
Book Value per Share (MRQ) i$54.95$30.02

Financial Statements Comparison: UFP Technologies Inc. vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricUFPT (2025)ABT (2025)
Revenue/Sales i602.80M44.33B
Cost of Goods Sold i432.39M19.32B
COGS % of Revenue i71.7%43.6%
Gross Profit i170.41M25.01B
Gross Margin i28.3%56.4%
Research & Development iN/A2.94B
Operating Income (EBIT) i92.97M8.05B
Operating Margin i15.4%18.2%
EBITDA i112.10M12.03B
EBITDA Margin i18.6%27.1%
Pre-Tax Income i82.51M8.47B
Pre-Tax Income % of Revenue i13.7%19.1%
Income Tax i14.20M1.94B
Income Tax % of Revenue i2.4%4.4%
Net Income (Profit) i68.31M6.52B
Profit Margin i11.3%14.7%

Balance Sheet & Liquidity Metrics

MetricUFPT (2025)ABT (2025)
Cash & Equivalents i20.30M8.52B
Total Current Assets i201.00M26.00B
Total Current Assets % of Revenue i33.3%58.6%
Total Current Liabilities i74.86M16.50B
Total Current Liabilities % of Revenue i12.4%37.2%
Long-Term Debt i136.95M10.83B
Long-Term Debt % of Revenue i22.7%24.4%
Total Shareholders Equity i423.88M52.77B
Retained Earnings i374.81M49.78B
Retained Earnings % of Revenue i62.2%112.3%
Property, Plant & Equipment i18.88M17.57B

Cash Flow Statement Comparison

MetricUFPT (2025)ABT (2025)
Operating Cash Flow i96.45M10.80B
Operating Cash Flow % of Revenue i16.0%24.4%
Capital Expenditures i-12.88M-2.17B
Free Cash Flow i78.98M7.40B
FCF Margin i13.1%16.7%
Debt Repayment i-122.68M-1.50B
Common Stock Repurchase iN/A-893.00M

Short Interest & Institutional Ownership Analysis

MetricUFPTABT
Shares Short i1.18M23.83M
Short Ratio i6.261.93
Short % of Float i18.60%1.53%
Shares Outstanding i7.71M1.74B
Float Shares i7.42M1.73B
% Held by Insiders i4.24%0.54%
% Held by Institutions i117.39%82.23%
% Held by Public i-21.63%17.23%

Dividend Analysis & Yield Comparison: UFP Technologies Inc. vs Abbott Laboratories

MetricUFPTABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026